LIBERIA (2011): MAP STUDY EVALUATING THE AVAILABILITY OF CONDOMS, HOUSEHOLD WATER TREATMENT PRODUCTS, ANTIMALARIALS, AND CONTRACEPTIVES 1st ROUND

PSI/Liberia was founded in 2008 to work in partnership with the Ministry of Health and Social Welfare to implement the Basic Package of Health Service component of the National Health Plan. Specifically, this MAP study aimed at assessing the availability of condoms, WaterGuard and other household water treatment products, oral and injectable contraceptives and malaria treatment drugs throughout the country. This information can be vital for the sales and marketing teams in prioritizing their efforts, both for the two existing PSI products and as a baseline for the distribution of two potential new health products (ACTs and oral contraceptives). Up to now, no such availability studies have been conducted in Liberia; results are thus expected to be of use to a range of key stakeholders in the public health sector of the country, particularly to the Ministry of Health and Social Welfare, the National AIDS and STI Control Program, the National Malaria Control Program, and public health NGOs.] [The MAP methodology employs the Lot Quality Assurance Sampling (LQAS) technique to draw a random sample of 19 enumeration areas (EAs) from each of five supervision areas (Greater Monrovia, South East, South Central, North West, North Central). This LQAS assessment of coverage determines the proportion of enumeration areas in which a product is available in each of these regions. Very low populated and inaccessible areas were excluded from the study. All outlets in the selected EAs were audited, including health facilities, pharmacies/drug stores, private clinics, medicine vendors, small shops (kiosks, business centers), street vendors, etc. For condoms, entertainment venues such as bars, night clubs and hotels were also visited. Additional information was collected on the source of supply of PSI products, reasons for not selling a particular product, interest in selling condoms/WaterGuard the products for outlets which never stocked the product. Data was collected in May 2011.

PSI/利比里亚（PSI/Liberia）成立于2008年，旨在与利比里亚卫生与社会福利部携手合作，落实《国家卫生计划》中的基本卫生服务包相关工作。本MAP研究的核心目标为：全面评估国内避孕套、WaterGuard及其他家用净水产品、口服与注射避孕药，以及疟疾治疗药物的可及性。该信息对于销售与营销团队优化工作优先级至关重要——既可为两款现有PSI旗下产品的推广提供决策依据，也可为两款潜在全新卫生产品（青蒿素联合疗法ACTs与口服避孕药）的分销设定基线数据。截至目前，利比里亚境内尚未开展过此类可及性评估研究，因此本研究结果将可为该国公共卫生领域的众多关键利益相关方提供助力，其中尤其包括卫生与社会福利部、全国艾滋病与性传播感染控制项目、全国疟疾控制项目，以及公共卫生领域非政府组织。
本研究采用的MAP方法学采用批量质量保证抽样（Lot Quality Assurance Sampling, LQAS）技术，从五大监管区域（大蒙罗维亚区、东南区、中南区、西北区、中北区）中各随机抽取19个普查区（enumeration areas, EAs）作为样本。该LQAS覆盖率评估将测算各区域内有相关产品在售的普查区占比。本研究排除了人口极度稀少且难以抵达的区域。对抽中普查区内的所有销售网点均开展了调研审核，涵盖医疗机构、药房/药店、私人诊所、药品商贩、小型商铺（报刊亭、商务中心）、街头商贩等。针对避孕套，研究团队还走访了酒吧、夜总会、酒店等娱乐场所。此外，研究还收集了如下额外信息：PSI产品的供货来源、某款产品停售的原因，以及未备货的销售网点对销售避孕套/WaterGuard产品的意向。本研究的数据采集工作于2011年5月完成。